Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
Market Research Report : Medical diagnostics market in india 2014 - SampleNetscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
Abstract :
Netscribes’ latest market research report titled Medical Diagnostics Market in India 2014 analyses the growth of the market due to cutting edge technology which provides better disease diagnosis. The Indian diagnostics market can be divided into equipment, reagents and services. The service sector is characterized by a large number of laboratories in the unorganized sector, which are clustered in the suburban areas and metros. In order to have better regulations and proper definition for the market a clear and structured format is being established. The laboratories are rapidly expanding using various business models. Large numbers of laboratories are registered only with the state health departments and not recognized by NABL (National Accreditation Board for Testing and Calibration Laboratories under Department of Science and Technology, Govt. of India).
The market is driven by increasing number of lifestyle diseases, rise in life expectancy due to preventive healthcare practices and increasing medical tourism. Currently there is trend of diagnostic medical imaging due to innovation in the technology sector which is helping the market to grow. Few numbers of accredited labs and high dependence on imported medical diagnostics products are the challenges this market is facing. Even though a range of diagnostic tests for various diseases are available in the market, there is a need for more reliable and better diagnostics. The market is dominated by private diagnostics companies in India who are expanding in Tier I and Tier II cities. Providing after-sales services for medical instruments and competitive pricing of the tests will catalyze the growth of the diagnostic sector.
Table of Contents :
Slide 1: Executive Summary
Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 – Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 – Jul 2013), Exchange Rate: Half Yearly (Aug 2013 – Jan 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2009-10, 2010-11, 2011-12, 2012-13), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)
Introduction
Slide 5: Medical Diagnostics Sector – Overview
Market Overview
Slide 6: Medical Diagnostics– Market Overview Forecasted Market Size and Growth (Value-Wise; 2013 – 2018e)
Slide 7: Medical Diagnostics Market – Overview of Franchise Business Model
Slide 8: Medical Diagnostics Market – Overview of Other Business Models
Slide 9: Accreditation of Laboratories
Slide 10: Technological Developments Used for the Diagnosis of a Wide Spectrum of Infectious Diseases
Drivers & Challenges
Slide 11: Medical Diagnostics Market – Drivers and Challenges summary
Slide 12-16: Drivers
Slide 17-18: Challenges
Trends
Slide 19: Trends – Summary
Slide 20-22: Trends
Go
Market Research Report : Medical diagnostics market in india 2014 - SampleNetscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
Abstract :
Netscribes’ latest market research report titled Medical Diagnostics Market in India 2014 analyses the growth of the market due to cutting edge technology which provides better disease diagnosis. The Indian diagnostics market can be divided into equipment, reagents and services. The service sector is characterized by a large number of laboratories in the unorganized sector, which are clustered in the suburban areas and metros. In order to have better regulations and proper definition for the market a clear and structured format is being established. The laboratories are rapidly expanding using various business models. Large numbers of laboratories are registered only with the state health departments and not recognized by NABL (National Accreditation Board for Testing and Calibration Laboratories under Department of Science and Technology, Govt. of India).
The market is driven by increasing number of lifestyle diseases, rise in life expectancy due to preventive healthcare practices and increasing medical tourism. Currently there is trend of diagnostic medical imaging due to innovation in the technology sector which is helping the market to grow. Few numbers of accredited labs and high dependence on imported medical diagnostics products are the challenges this market is facing. Even though a range of diagnostic tests for various diseases are available in the market, there is a need for more reliable and better diagnostics. The market is dominated by private diagnostics companies in India who are expanding in Tier I and Tier II cities. Providing after-sales services for medical instruments and competitive pricing of the tests will catalyze the growth of the diagnostic sector.
Table of Contents :
Slide 1: Executive Summary
Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 – Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 – Jul 2013), Exchange Rate: Half Yearly (Aug 2013 – Jan 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2009-10, 2010-11, 2011-12, 2012-13), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)
Introduction
Slide 5: Medical Diagnostics Sector – Overview
Market Overview
Slide 6: Medical Diagnostics– Market Overview Forecasted Market Size and Growth (Value-Wise; 2013 – 2018e)
Slide 7: Medical Diagnostics Market – Overview of Franchise Business Model
Slide 8: Medical Diagnostics Market – Overview of Other Business Models
Slide 9: Accreditation of Laboratories
Slide 10: Technological Developments Used for the Diagnosis of a Wide Spectrum of Infectious Diseases
Drivers & Challenges
Slide 11: Medical Diagnostics Market – Drivers and Challenges summary
Slide 12-16: Drivers
Slide 17-18: Challenges
Trends
Slide 19: Trends – Summary
Slide 20-22: Trends
Go
This is a Dean's Case Competition project in Som-Binghamton University. I did it with my team in Spring 2014 to present our the overall situation of Medtronic Inc.
Thyrocare Technologies Limited claims to be India’s most advanced totally automated laboratory having its strong presence in more than 2000 cities / towns in India and internationally.
The company was started in 1996, by Dr Velumani Arokiaswamy with a staff of 4 people, with focus on low cost Thyroid testing.
By 2014, it has become India’s most profitable diagnostic business. The company has a highly differentiated business model. It is more of a B2B company, collecting samples from hundreds of dedicated collection points, and also from allied labs. All processing is done in one highly automated lab near Mumbai.
India pharmacy retail market report -2020 |India Pharmacy Retail MarketKen Research Pvt ltd.
India Pharmacy Retail Market Outlook to 2020 – Growth Driven by Surge in OTC Drugs Sales and Expansion of Online Pharmacies” provides a comprehensive analysis of the various aspects such as market size of the India Pharmacy Retail and Online Pharmacy Retail Market. The report also covers the market segmentation on the basis of organized & unorganized pharmacies, prescribed drugs, OTC drugs & private label products, category of drugs and generic & patented drugs. The report shares the company profile and competitive landscape for major players in the organized pharmacy sector and online pharmacy market.
Pharmacy retail market in India is driven by growth in the pharmaceutical sector, registered revenues of INR ~ billion in FY’2015. With the advent of online pharmacy retailers in the market, the industry is likely to witness a surge in the coming future. The retail pharmacy in the India has escalated at a CAGR of 19.4% from INR ~ billion in FY’2010 to INR ~ billion in FY’2015. The surge in growth is chiefly guided by the escalation in urbanization, increase in household expenditures, increasing smartphone users, need for convenience and rising literacy rate in the country coupled with growing medical awareness.
2nd Med Device Brochure | 16-19 Nov 2015 SingaporeHelen P
Med Device Asia is the only senior industry gathering in Asia for medical device companies, manufacturers, investors and other stakeholders to promote innovation, accelerate approvals and explore the fastest way to market expansion.
Rise of Retail Chemist Power in India - MedicinMan Anup Soans
With increasing push towards generics being mandated by government of India and Medical Council of India and Civil Society, Will the Retail Chemist emerge stronger in his bargaining power?
The pharmacy retail market is valued at INR 216 bn in 2009 and estimated to reach INR 432 bn in 2011. The market is fragmented and dominated by the unorganized sector.
The report provides a snapshot of the pharmacy retail market. Market overview gives a quick picture of the market with estimated market size, growth rate and revenue split between the organized and unorganized sector. An analysis of drivers reveals that growth in pharmaceuticals sector, increase in healthcare spending, changing disease profile, consumer attitudes, attractive margins and growth in OTC segment is driving growth in this sector. The key challenges identified include fragmented nature of Industry, lengthy supply chain, counterfeit drugs and FDI Regulations.
The report identifies the current market trends including loyalty schemes, value added services, tie-ups with retail firms, rural expansion, entry of Government in pharmacy retailing, entry of private labels, organized retailers starting pharmacy chains. The competitive landscape profiles the major players in this sector including the business description, number of stores and expansion plans for each player. The report also provides details of the key developments in this sector.
Most fastest growing pharmaceutical companies in 2021Swiftnlift
Over the past two decades, the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centres, and the medical profession itself.
This document brings together a set of latest data points and publicly available information relevant for Healthcare Industry. We are very excited to share this content and believe that readers will benefit from this periodic publication immensely.
Healthcare marketing the optimization scenario1Nirmala N
In recent times Marketing Management is becoming more challenging and highly expensive. Organizations are realizing that internal resources are not enough to produce measurable results in a consistent manner. They face hardcore challenges in standardization and corporatization. The bare minimum fact in an Organization is that they are unable to fix the GAP between Operations and Marketing.
Optimize offers to undertake areas of challenges in an Organization and help Organizations to get optimized results even with minimal resources. Resources need to be optimized and not just utilized, and we empower you to achieve those results.
This is a Dean's Case Competition project in Som-Binghamton University. I did it with my team in Spring 2014 to present our the overall situation of Medtronic Inc.
Thyrocare Technologies Limited claims to be India’s most advanced totally automated laboratory having its strong presence in more than 2000 cities / towns in India and internationally.
The company was started in 1996, by Dr Velumani Arokiaswamy with a staff of 4 people, with focus on low cost Thyroid testing.
By 2014, it has become India’s most profitable diagnostic business. The company has a highly differentiated business model. It is more of a B2B company, collecting samples from hundreds of dedicated collection points, and also from allied labs. All processing is done in one highly automated lab near Mumbai.
India pharmacy retail market report -2020 |India Pharmacy Retail MarketKen Research Pvt ltd.
India Pharmacy Retail Market Outlook to 2020 – Growth Driven by Surge in OTC Drugs Sales and Expansion of Online Pharmacies” provides a comprehensive analysis of the various aspects such as market size of the India Pharmacy Retail and Online Pharmacy Retail Market. The report also covers the market segmentation on the basis of organized & unorganized pharmacies, prescribed drugs, OTC drugs & private label products, category of drugs and generic & patented drugs. The report shares the company profile and competitive landscape for major players in the organized pharmacy sector and online pharmacy market.
Pharmacy retail market in India is driven by growth in the pharmaceutical sector, registered revenues of INR ~ billion in FY’2015. With the advent of online pharmacy retailers in the market, the industry is likely to witness a surge in the coming future. The retail pharmacy in the India has escalated at a CAGR of 19.4% from INR ~ billion in FY’2010 to INR ~ billion in FY’2015. The surge in growth is chiefly guided by the escalation in urbanization, increase in household expenditures, increasing smartphone users, need for convenience and rising literacy rate in the country coupled with growing medical awareness.
2nd Med Device Brochure | 16-19 Nov 2015 SingaporeHelen P
Med Device Asia is the only senior industry gathering in Asia for medical device companies, manufacturers, investors and other stakeholders to promote innovation, accelerate approvals and explore the fastest way to market expansion.
Rise of Retail Chemist Power in India - MedicinMan Anup Soans
With increasing push towards generics being mandated by government of India and Medical Council of India and Civil Society, Will the Retail Chemist emerge stronger in his bargaining power?
The pharmacy retail market is valued at INR 216 bn in 2009 and estimated to reach INR 432 bn in 2011. The market is fragmented and dominated by the unorganized sector.
The report provides a snapshot of the pharmacy retail market. Market overview gives a quick picture of the market with estimated market size, growth rate and revenue split between the organized and unorganized sector. An analysis of drivers reveals that growth in pharmaceuticals sector, increase in healthcare spending, changing disease profile, consumer attitudes, attractive margins and growth in OTC segment is driving growth in this sector. The key challenges identified include fragmented nature of Industry, lengthy supply chain, counterfeit drugs and FDI Regulations.
The report identifies the current market trends including loyalty schemes, value added services, tie-ups with retail firms, rural expansion, entry of Government in pharmacy retailing, entry of private labels, organized retailers starting pharmacy chains. The competitive landscape profiles the major players in this sector including the business description, number of stores and expansion plans for each player. The report also provides details of the key developments in this sector.
Most fastest growing pharmaceutical companies in 2021Swiftnlift
Over the past two decades, the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centres, and the medical profession itself.
This document brings together a set of latest data points and publicly available information relevant for Healthcare Industry. We are very excited to share this content and believe that readers will benefit from this periodic publication immensely.
Healthcare marketing the optimization scenario1Nirmala N
In recent times Marketing Management is becoming more challenging and highly expensive. Organizations are realizing that internal resources are not enough to produce measurable results in a consistent manner. They face hardcore challenges in standardization and corporatization. The bare minimum fact in an Organization is that they are unable to fix the GAP between Operations and Marketing.
Optimize offers to undertake areas of challenges in an Organization and help Organizations to get optimized results even with minimal resources. Resources need to be optimized and not just utilized, and we empower you to achieve those results.
Learning Technologies Group - NOAH15 BerlinNOAH Advisors
Education Challengers - Presentation by Jonathan Satchell, Chief Executive of Learning Technologies Group at the NOAH 2015 Conference in Berlin, Tempodrom on the 9th of June 2015.
Striving for Success in 2017 for Remodeling Businesses with Mark RichardsonSurefire Local
Mark Richardson shows you the 3 key ingredients for success, how to position your business for future success, where most businesses fail and how to avoid the same mistakes, and how your business can plan for a prosperous 2017. This is one video you won't want to lose!
Kobo: Data For Breakfast - Analysis and Sales-Driven Culture (Michael Tambly...Kobo
(From the Digital Book World panel: Consumer Sales Data: Getting It, Analyzing It, Using It)
How does Kobo use data analysis by the minute, hour and day to succeed in the furiously competitive ebook market? This presentation shows a day in the life of Kobo and how we use analysis to drive sales, win fans and serve customers.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
State Of Healthcare Q2’21 Report: Investment & Sector Trends To Watch. Contents include Summary, Market Drivers, Investment Trends, Sector Highlights (AI, Health IT, Omics, telehealth, digital therapeutics, mental health, medical devices, digital health, etc). Global healthcare investment rose for the seventh consecutive quarter. European investment nearly doubled. A flood of new entrants pushed early-stage deal share
above 50%. M&A activity persisted. The top healthcare deals in the quarter (by deal size) went to companies working in life sciences. The SPAC frenzy continued within digital health. Eleven healthcare startups joined the unicorn club during
Q2’21 (valued in aggregate at $27B).
Health Technology startup quarterly highlights. Includes a sector summary, recent events, and a deep dive into Digital Medical Devices. Contact info@venturescanner.com or visit www.venturescanner.com to learn more about our research platform for technology startups!
Our analysis regarding the evolution of what we believe is the development of the Healthcare Cloud. We discuss the siloed nature of HCIT in terms of legacy and cloud and discuss how we believe entities need to shift from point to platform solutions over time. We also lay out the fundamental underpinnings of what makes a compelling digital healthcare investment.
Health Systems Share COVID-19 Financial Recovery Strategies in First Client H...Health Catalyst
More than 100 attendees joined the first of a series of Health Catalyst virtual client huddles designed to support client partners and aid collaboration and direct client connections in this time of unprecedented change. According to an April 2020 survey of Health Catalyst clients, 72.6 percent said they had a strong interest in examples, guidance, and tools from other health systems. In the client-only session, insights shared included the most common COVID-19 analytic projects and one health system’s elective surgery plan.
The health system shared the challenges they faced in understanding the financial impact of halting elective surgeries as well as creating a plan for working through their backlog. They also shared the tools and strategies they are using to aid their financial recovery.
FINN Partners Global State of Digital Health Q3 2022Levi Shapiro
Global State of Digital Health, Q3 2022, prepared by Finn Partners and Galen Growth.
While most analyses suggest digital health investment is declining, that’s a superficial assessment. Last year – when patients were separated from the health professional community – investors from all sectors jumped in with investments to learn and save their business models. That investment surge was from exuberance. Now, the monies being deployed are strategic. More important, 2022 numbers are far higher than the pre-pandemic equity invested in 2019.
While more than 60% of the total venture funding value comes from North America, on a regional level, the Middle East (primarily Israel by 92% and the United Arab Emirates) set record highs in venture funding in Q2 2022. Europe maintains momentum throughout 2022 and has not experienced the quarter-on-quarter decrease in venture funding seen in North America. Regions with increased investment correspond to established regulatory, public health and payer systems that prioritize digital health use. Israel – and Israeli-based entrepreneurs – need to keep their profiles high.
The 10 companies booming in healthcare sector smallinsightscare
Development is a continuous process in any sector. It brings in more comfort, more precision, and more enhanced way of living.Acknowledging the remarkable contribution of the leading companies in the care sector, we bring to you the special issue of “The 10 Companies Booming in Healthcare Sector”.
mHealth Israel_PwC Top Health Industry Issues of 2020Levi Shapiro
Review of 2020's top healthcare issues, by Ben Isgur, Head, PwC Health Research Institute:
1) A looming tsunami of high prices
2) Regulations trumps policy
3) Consumers inch closer to DIY healthcare
4) A whole new you- deals as makeovers
5) Equity and inclusion, not just diversity, as a business imperative
6) US health organizations are seeking opportunities overseas and through innovation. Beware of the tax risks
7) Fast- forwarding from data to decisions
The Catalyst @ Health 2.0/Wipfli Survey on the State of Digital Health 2021 -...health2dev
The final results are in! Take a look now to see the output of the analysis on the Catalyst @ Health 2.0/Wipfli Survey on the State of Digital Health - 2021!
The 2018 AMR API study from Health 2.0. A survey of the experience of the small health tech application companies working with the large EMR vendors. This is an update and expansion of a similar 2016 study. Both studies supported by the California Health Care Foundation.
With support from California Health Care Foundation, earlier this year (2016) Health 2.0 surveyed over 100 small health tech companies to ask their experiences integrating with specific EMR vendors.
FoodCare helps food and beverage businesses understand and meet the needs of millions of individuals and families by providing nutrition-related apps and services.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Health 2.0 Quarterly Report (Q2 2016)
1. HEALTH 2.0 QUARTERLY REPORT :: Q2 2016
QUARTERLYREPORTS
HEALTH 2.0 QUARTERLY REPORT :: Q2 2016
BROUGHT TO YOU BY:
2. HEALTH 2.0 QUARTERLY REPORT :: Q2 2016
REGULATORY HICCUPS
Health tech is still finding its footing with regulators. Zenefits devalued itself from
$4.5B to $2B after it violated state laws by selling health insurance with unlicensed
brokers. The FDA declined to approve Proteus’ sensor technology in anti-psychotic
pills, asking for more testing. In South Carolina, special interests blocked use of eye
exam kiosks and self-exams, causing eye startup Opternative to cease operations
in the state. On a better note, Texas is working to improve its telehealth laws.
META DATA
As more digital health companies emerge,a need to effectively sift through all of them
does also. Evidation Health ($11.6M), a joint venture of Stanford and GE Ventures, will
study the efficacy of health tech solutions through research. Ranked Health, an app
curation solution out from nonprofit Hacking Medicine, offers professional reviews of
other health apps. Jiff ($17.7M) aggregates all employer-purchased digital health tools
in its own app so that employees can access the solutions more easily.
BEHAVIORAL HEALTH
Mental health continues to be an area of hot interest forhealth tech. Affectiva,
an emotion analytics platform, raised $14M this quarter. Teletherapy company
TalkSpace another $15M to expand its primarily text-based services. Constant
Therapy, a firm that uses big data to target digital brain exercises to stroke
patients, released promising data from its app and added 3 scientific advisors.
BIG MOVES
Corporate giants continue laying hands in SMACK health, and this quarter was no
different. Medtronic and Qualcomm are joining forces on a new continuous
glucose monitoring system. Apple released CareKit, an open source framework
for developers to design health tech applications. Nokia acquired medical
product company Withings for $200M.
Things We Care About, Q22016
3. HEALTH 2.0 QUARTERLY REPORT :: Q2 2016
1925
CONSUMER FACING
1019
PROFESSIONAL
FACING
361
PATIENT PROVIDER
COMMUNICATION
480
DATA, ANALYTICS,
& EXCHANGE
3785
ALL COMPANIES
Health 2.0 tracks companies in our Source Database
according to one of four categories, one or more of nineteen
sub-segments, and any number of additional tags. This
categorization schema, developed in 2011, is far more rigorous
that any we’ve seen and consistently lets us distinguish
apples from oranges in a particularly bountiful space.
HEALTH 2.0 SOURCE ticked up this quarter,
adding 60 companies overall.The Consumer
Facing category added 25 companies,and the
Professional Facing category added 7 companies.
The Patient Provider Communication category
added 18 firms,while the Data,Analytics, and
Exchange category added 10.
Health 2.0 Source:Total Companies By Category
HEALTH 2.0 SOURCE COMPANIES BY CATEGORY, JUNE 2016
4. HEALTH 2.0 QUARTERLY REPORT :: Q2 2016
The lion’s share is still in North America,with 75% of digital health
companies located there.However,a strong contingent belongsto
Europe with 17%,as emerging sectors in Asia,Latin America,MENA
and even Africa continue to expand.
AS THEHEALTH 2.0 COMMUNITY grows around the world,it’s
being reflected in the Source database.Here’s a map of the world
showing the global distributionof companies
Health 2.0 Around the World
.2%
.7%
.6%
1.4%
4.9%
17.4%
75.1%
5. HEALTH 2.0 QUARTERLY REPORT :: Q2 2016
2011
1.0 B 1.6 B 2.2 B
4.6 B 4.8B
2012
3.5 B
2016
2013
2014
2015
FUNDING FOR THEHEALTH 2.0 space is still
on pace to equal or top last year’s funding.
Approximately $1.78B was invested from April
through July.
Funding KeepsFlowing
Funding for the second quarter has bested all of
our estimates. Q2 of 2016 totaled a whopping
$1.78B in deals, more money than we saw in 2012
for the entire year, and $500M of that came from
just one deal. Digital health companies are
attracting record interest, and it seems a funding
slowdown is nowhere in sight.
HEALTH 2.0 ANNUAL FUNDING
6. HEALTH 2.0 QUARTERLY REPORT :: Q2 2016
2.4B
CONSUMER FACING
THE CONSUMER FACING category continued to drive
venture funding.Behemothinternational deals for Ping An
Good Doctor ($500M) and Chunyu Yisheng ($183M)
impacted this quarter’s funding talliesdramatically.
Consumer Facing Funding STILL On Top
227M
PROFESSIONAL
FACING
225M
PATIENT PROVIDER
COMMUNICATION
560M
DATA, ANALYTICS,
& EXCHANGE
Two of the biggest deals this quarter:
*183M* 500M
2016 FUNDING BY CATEGORY AND QUARTER
*Q2: 100M
Q1: 127M
Q1: 312M
Q2: 248M
Q1: 120M
Q2: 105M
Q1: 1.14B
*Q2: 1.3B
7. HEALTH 2.0 QUARTERLY REPORT :: Q2 2016
THE TOP DEALS of Q2 2016 totaled to
$1.05B and represent nearly 68% of total
funding this quarter.
Hot Stuff: Top Funding Deals in Q2, 2016
CONSUMER FACING PROFESSIONAL
FACING
PATIENT PROVIDER
COMMUNICATION
DATA, ANALYTICS,
& EXCHANGE
TOP FUNDING DEALS OF Q2 2016
This quarter highlights massive deals – our top 3 represent
43% of all funding – and the promise of Chinese healthcare.
Ping An ($500M) and Chunyu Yisheng ($183M) are both
medical consultation apps, while Codoon ($50M) offers
wellness products to Chinese consumers. Clearly, there is a
huge healthcare market in a country with a billion people .
Stateside, Bright Health ($80M), led by a former United
Healthcare CEO, looks to enter the health insurance
marketplace with a model to rival Oscar’s. EarlySense
($25M) produces continuous monitoring devices for
patients. Anomali ($30M), though not solely a SMACK
health firm, focuses on data compromise detection that is
essential for HIPAA compliance.
500M
200M
100M
50M
25M
8. HEALTH 2.0 QUARTERLY REPORT :: Q2 2016
0 5 10 15 20 25 30 35 40 45 50
B2B-Decision Support Analytics
Privacy & Identity
Data Utility Layer
B2B-Administrative Tools
B2B-Revenue Collection & Management
B2B-Clinician Workflow
Professional Knowledge Exchanges
Patient-Provider Communication
Provider Search
Coaching & Advisory Services
Personal Health Assessment & Diagnostic …
Clinical Trials Search & Recruitment
Gaming
Financial Management
Patient Communities
Search
Wellness
Content
Self-Management Tools & Trackers
This year, our team has added hundreds of products to Source. We
saw the greatest gains in wellness, consumer products across the
board and in data management solutions. We expect product
growth to continue its strong trajectory and accelerate into 2017
as digital health funding continues to flame.
THIS GRAPH SHOWS the percentage growth
in product additions to Health 2.0 Source by
segment. Our team has steadily added
products to the Source as they are released,
creating a product encyclopedia for expert
market insight.
If You Remember One Thing: Products Are Not Companies, Companies Are Not Products
CONSUMER FACING
PROFESSIONAL FACING
PATIENT PROVIDER
COMMUNICATION
DATA, ANALYTICS,
& EXCHANGE
PRODUCT GROWTH BY SEGMENT IN PAST 12 MONTHS, HEALTH 2.0 SOURCE, JUNE 2016
9. HEALTH 2.0 QUARTERLY REPORT :: Q2 2016
ABOUT HEALTH 2.0 MARKET INTEL
Since 2007, Health 2.0 has catalyzed, tracked, and showcased the SMACK
(social/sensor, mobile, analytics, cloud & kindness!) revolution in health
information technology. Our longevity and independent industry
positioning gives us an unrivaled depth of knowledge.
Health 2.0’s Market Intelligence offerings range from this quarterly data
release to custom market research reports, and subscription access to the
Health 2.0 Source Database.
The Health 2.0 Source database serves as the foundation of our intelligence
products and includes detailed data on more than 3,700 companies and
4,500 products. To learn more about Health 2.0 Market Intelligence
offerings, please visit health2con,com or email
marketintel@health2con.com
ABOUT THE QUARTERLY REPORT
The Quarterly Report represents a summary set of data that explains
where industry funding is going, which product segments are growing
fastest, and where new company formation is happening. Health 2.0’s
precision and clarity when it comes to market segmentation and product
information make this quarterly release the cream of the freebie crop.
This report is provided for informational purposes and was prepared
in good faith and good fun. This report is a proprietary aggregation of
publicly and some privately available data and shall not be reproduced in a
different format without written consent of Health 2.0
QUARTERLYREPORTS
QUARTERLY REPORT CONTRIBUTORS
Matthew Holt Co-Chairman Prerna Anand Data Analyst Rachael Charbonneau Graphic Designer Sofia Noori Data Intern
10. HEALTH 2.0 QUARTERLY REPORT :: Q2 2016
ABOUT
Health 2.0 is the premiere showcase and catalyst for the advancement of
new health technologies. Through a global series of conferences, thought
leadership roundtables, developer competitions, pilot programs, and
leading market intelligence, Health 2.0 drives the innovation and
collaboration necessary to transform health and health care.
For more information visit health2con.com
HEALTH 2.0 QUARTERLY REPORT :: Q2 2016